CRL
Charles River Laboratories InteHealthcare$173.89
▼ Bearish
Mkt Cap: $8.56B|Float: 48.7M|SI: 7.7%|DTC: 3.1
Data as of market close Apr 2, 2026
IV Rank
94
IV Pctl
78%
HV 20d
5603.0%
52W Range
$92-$229
ATR(14)
$6.98
Exp. Move
±8.0%
P/C Ratio
1.00
Earnings
May 6
GEX Negative
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
CRL Key Options Data
- IV Rank
- 93.5%
- Total GEX
- $-0.00B
- Total DEX
- $0.1M
- Max Pain
- $165.00
- Expected Move
- ±8.0%
- Put/Call OI
- 1.00
- Net Premium
- $0.9M
- Spot Price
- $173.89
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$13.85 | ±8.0% | $160.04 | $187.74 |
| 2026-05-15 | 43 | ±$24.65 | ±14.2% | $149.24 | $198.54 |
| 2026-07-17 | 106 | ±$36.80 | ±21.2% | $137.09 | $210.69 |
| 2026-08-21 | 141 | ±$21.20 | ±12.2% | $152.69 | $195.09 |
| 2026-10-16 | 197 | ±$29.75 | ±17.1% | $144.14 | $203.64 |
| 2026-12-18 | 260 | ±$29.85 | ±17.2% | $144.04 | $203.74 |
Explore CRL options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.